Nifuroxazide

Spécifications

965-52-6Numéro CAS

213-522-0Numéro CE

4-hydroxy-N-[(E)-(5-nitrofuran-2-yl)methylideneamino]benzamideNom IUPAC

C12H9N3O5Formule chimique

275.22 g/molMasse molaire

Nifuroxazide; 965-52-6; Nifuroxazida; Nifuroxazidum; RC-27109; NSC-759261; p-Hydroxybenzoic acid (5-nitrofurfurylidene)hydrazide; PM5LI0P38J; SJ000287313; DTXCID2025343; DTXSID4045343; 4-hydroxy-N-((5-nitrofuran-2-yl)methylideneamino)benzamide; 4-hydroxy-N-[(5-nitrofuran-2-yl)methylideneamino]benzamide; 4-hydroxy-N'-((1E)-(5-nitrofuran-2-yl)methylidene)benzohydrazide; 4-hydroxy-N'-[(1E)-(5-nitrofuran-2-yl)methylidene]benzohydrazide; Ercefuryl 200; RefChem:165799; A07AX03; 213-522-0; Dicoferin; Nifuroxazid; MFCD00079482; Diarlidan; Ercefuryl; MLS000069620; 4-Hydroxy-N'-((5-nitrofuran-2-yl)methylene)benzohydrazide; 4-hydroxy-N-[(E)-(5-nitro-2-furyl)methyleneamino]benzamide; Ercefurol; 4-hydroxy-N-[(E)-(5-nitrofuran-2-yl)methylideneamino]benzamide; p-Hydroxybenzoic acid 5-nitrofurfurylidene hydrazide; (5-Nitro-2-furfurylidene)(4-hydroxybenzoyl)hydrazine; Nifuroxazide (INN); pentofuryl; SMR000058185; (E)-4-hydroxy-N'-((5-nitrofuran-2-yl)methylene)benzohydrazide; NIFUROXAZIDE [INN]; Benzoic acid, 4-hydroxy-, 2-[(5-nitro-2-furanyl)methylene]hydrazide; Nifuroxazidum [INN-Latin]; Nifuroxazida [INN-Spanish]; 4-hydroxy-N'-[(5-nitrofuran-2-yl)methylidene]benzohydrazide; CCRIS 5490; RC 27109; R.C. 27-109; EINECS 213-522-0; 5-Nitro-2-furaldehyde p-hydroxybenzoylhydrazone; UNII-PM5LI0P38J; BRN 1352180; Diaryl; Nifuroxazide [INN:BAN:DCF]; Bacifurane;; Diarlidan;; Dicoferin;; Ercefuril;; Ambatrol;; Panfurex;; Antinal;; Diarret;; Nifuroxazide CRS; 4-Hydroxy-N'-(5-nitrofurfuryliden)benzhydrazid; NCGC00016554-01; CAS-965-52-6; Prestwick_874; (Nitro-5' furfurylidene-2') hydroxy-4 benzhydrazide; Opera_ID_40; Nifuroxazide (Standard); (Nitro-5' furfurylidene-2') hydroxy-4 benzhydrazide [French]; BENZOIC ACID, p-HYDROXY-, (5-NITROFURFURYLIDENE)HYDRAZIDE; Prestwick2_000555; Prestwick3_000555; BSPBio_000629; NIFUROXAZIDE [MART.]; NIFUROXAZIDE [WHO-DD]; SCHEMBL542542; BPBio1_000693; CHEMBL244888; orb1308168; orb3025274; SCHEMBL14608895; CHEBI:94556; GTPL12358; HY-B1436R; CHEBI:135136; HMS1569P11; HMS2096P11; HMS3713P11; HMS5082L06; NIFUROXAZIDE [EP IMPURITY]; Pharmakon1600-01505788; NIFUROXAZIDE [EP MONOGRAPH]; HY-B1436; Tox21_110491; BDBM50396177; EBC-03915; EBC-06930; MSK159800; NSC759261; s4182; STK091243; AKOS000483758; Tox21_110491_1; AC-8713; CCG-213989; CS-4918; DB13855; FN26215; NSC 759261; NCGC00179496-04; AS-13310; SY102095; BIM-0014420.P001; SBI-0014420.P002; AB00513861; D07111; E75897; AB00513861_02; AB00513861_03; EN300-1692886; Nifuroxazide, VETRANAL(TM), analytical standard; EN300-21037331; F847795; Q822929; BRD-K68188368-001-03-7; BRD-K68188368-001-08-6; BRD-K68188368-001-09-4; BRD-K68188368-001-11-0; Q27166394; Z49615787; 4-hydroxy-N-[(5-nitro-2-furanyl)methylideneamino]benzamide; 4-hydroxy-N'-[(1E)-(5-nitro-2-furyl)methylene]benzohydrazide; Nifuroxazide, European Pharmacopoeia (EP) Reference Standard; 4-hydroxy-N'-[(E)-(5-nitrofuran-2-yl)methylidene]benzohydrazide; 4-Hydroxybenzoic acid 2-[(5-nitro-2-furanyl)methylene]hydrazide; Benzoic acid, 4-hydroxy-, [(1E)-(5-nitro-2-furanyl)methylene]hydrazideSynonymes